H. Farrelly

T CELL DEPLETION OF BONE MARROW FOR CLINICAL MARROW ALLOGRAFTING: OPTIMALIZATION OF CONDITIONS FOR DEPLETION BY ANTI‐CD2 AND ANTI‐CD8 MONOCLONAL ANTIBODIES WITH RABBIT COMPLEMENT, AND FOR DETECTION OF RESIDUAL T CELL CONTENT

J. Biggs, K. Atkinson, M. Cooley, 1987, Pathology.

Opsonic monoclonal antibodies against lipopolysaccharide antigens of Leptospira interrogans serovar hardjo.

S Faine, B. Adler, B Adler, 1987, Journal of medical microbiology.

Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease.

K. Atkinson, J. Biggs, M. Cooley, 1987, Bone marrow transplantation.

A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy.

J. Biggs, K. Atkinson, A. Dodds, 1987, Australian and New Zealand journal of medicine.

CD4+ T cells appear capable of initiating graft-versus-host disease across non-major histocompatibility complex (MHC) barriers in man.

K. Atkinson, J. Biggs, M. Ashby, 1987, Bone marrow transplantation.